DrugPatentWatch Database Preview
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE Drug Profile
» See Plans and Pricing
When do Buprenorphine Hydrochloride And Naloxone Hydrochloride patents expire, and when can generic versions of Buprenorphine Hydrochloride And Naloxone Hydrochloride launch?
Buprenorphine Hydrochloride And Naloxone Hydrochloride is a drug marketed by Alvogen Pine Brook, Dr Reddys Labs Sa, Mylan Technologies, Actavis Elizabeth, Amneal Pharms, Ethypharm Usa Corp, Hikma, Lannett Co Inc, Mayne Pharma Inc, Rhodes Pharms, Specgx Llc, Sun Pharm, Teva Pharms Usa, and Wes Pharma Inc. and is included in sixteen NDAs.
The generic ingredient in BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Buprenorphine Hydrochloride And Naloxone Hydrochloride
A generic version of BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE was approved as buprenorphine hydrochloride; naloxone hydrochloride by ACTAVIS ELIZABETH on February 22nd, 2013.
Summary for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 14 |
NDAs: | 16 |
Suppliers / Packagers: | 19 |
Bulk Api Vendors: | 1 |
Clinical Trials: | 112 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE at DailyMed |

Recent Clinical Trials for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Wistar Institute | Phase 2 |
IMEA Paris | Phase 2 |
National Institute of Drug Abuse | Phase 2 |
See all BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE clinical trials
Pharmacology for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Drug Class | Opioid Antagonist Partial Opioid Agonist |
Mechanism of Action | Opioid Antagonists Partial Opioid Agonists |